Advances in exosomal non-coding RNAs in cervical cancer (Review)
Xingkui Xie1, Hongwei Guan2, Meng Li3
1Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Molecular and Clinical Oncology
|October 29, 2025
Summary
Exosomes carrying non-coding RNAs are key in cervical cancer (CC) development, influencing tumor growth and drug resistance. Further clinical trials are needed to confirm their safety and efficacy for CC diagnosis and therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Exosomes are extracellular vesicles mediating intercellular communication.
- Non-coding RNAs (ncRNAs) within exosomes play roles in various diseases.
- Cervical cancer (CC) pathogenesis involves complex molecular mechanisms.
Purpose of the Study:
- To elucidate the role of exosomal ncRNAs in cervical cancer (CC) development.
- To explore the potential of exosomal ncRNAs as biomarkers and therapeutic targets for CC.
- To review current challenges in translating exosome-based therapies for CC.
Main Methods:
- Literature review focusing on exosomal non-coding RNAs in cervical cancer.
- Analysis of molecular mechanisms underlying exosome-mediated intercellular communication in CC.
- Synthesis of data on diagnostic, therapeutic, and prognostic potential of exosomal ncRNAs.
Main Results:
- Exosomal ncRNAs (miRNAs, lncRNAs, circRNAs) critically influence CC initiation, progression, metastasis, angiogenesis, and drug resistance.
- These ncRNAs show promise as novel biomarkers for CC diagnosis and prognosis.
- Exosomes offer potential as therapeutic delivery vehicles for CC treatment.
Conclusions:
- Exosomal ncRNAs are significant contributors to cervical cancer pathogenesis and progression.
- Further clinical validation is required to establish the safety and efficacy of exosome-based therapies for CC.
- Standardization of isolation, storage, drug loading, and clinical trials are crucial for exosome translation in CC treatment.
Related Concept Videos
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
02:39lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
01:36Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K